The present invention relates to a haemostatic bio-material composition and method for achieving hemostasis. The method for providing hemostasis generally comprises: supplying a dry potassium phosphate based hemostat mixture comprising: monobasic potassium phosphate, a metal oxide, and a tertiary calcium phosphate, wherein the weight percent ratio of monobasic potassium phosphate to metal oxide is between about 3:1 and 1:1 mixing the dry potassium phosphate based hemostat mixture with an aqueous solution forming an activated hemostat slurry applying an hemostasis-promoting amount of the activated potassium phosphate based hemostat slurry to a site of bleeding wherein the site of bleeding is in, on, or proximate to bone.
